hristio.bsky.social
hristio.bsky.social
@hristio.bsky.social
The year started with another collaboration with Piotr Ozieranski and Shai Mulinari, in which we showed that the UK’s pharmaceutical industry self governing body has developed a major backlog in handling complaints over drug companies’ marketing practices www.bmj.com/content/384/...
Delays in dealing with complaints against drug companies are growing, BMJ finds
A major backlog has developed in handling complaints over drug companies’ marketing practices in the UK. Hristio Boytchev , Shai Mulinari , and Piotr Ozieranski report Processing times for complaints...
www.bmj.com
December 31, 2024 at 10:20 PM
Turning to the alcohol industry, Madlen Davies and I showed how it is involved in drinking awareness campaigns in schools and universities www.bmj.com/content/385/...
Big alcohol: Universities and schools urged to throw out industry-funded public health advice
The long term harms of alcohol are being minimised in industry funded education, find Madlen Davies and Hristio Boytchev Universities and schools are being urged to join a growing movement in Irelan...
www.bmj.com
December 31, 2024 at 10:20 PM
In another tobacco investigation, Irene van den Berg, Mathilde de Jeu and I showed how the tobacco industry is still funding medical research, published in medical journals www.bmj.com/content/385/...
Tobacco funded research: how even journals with bans find it hard to stem the tide of publications
Tobacco companies are investing billions in pharmaceutical and medical products. These ties complicate the ongoing efforts of researchers, scientific organisations, and journals to distance themselves...
www.bmj.com
December 31, 2024 at 10:20 PM
In a follow up piece, Matthew Chapman and I broke further details of the collaboration as well as Medscape’s backing away from it www.bmj.com/content/385/...
Later, the WHO denounced “tobacco industry's manipulation of medical education” www.who.int/republicofko...
Medscape caves in on courses funded by tobacco giant Philip Morris, while medics fear global push into medical education
Clinic demonstrations, podcasts, and TV shows: Hristio Boytchev reveals how an ambitious deal between a leading medical education provider and the tobacco industry collapsed this week The medical edu...
www.bmj.com
December 31, 2024 at 10:20 PM
Earlier in the year, I broke the story of tobacco giant Philip Morris International funding smoking cessation courses on the leading medical education platform Medscape www.bmj.com/content/385/...
Exclusive: Outcry as Philip Morris International funds smoking cessation courses on Medscape
A leading medical information company has been urged to cancel a series of new education courses on smoking cessation funded by the tobacco industry giant Philip Morris International (PMI). Physician...
www.bmj.com
December 31, 2024 at 10:20 PM
The story made the front page of the Washington Post and the German line of the investigation, led by Paper Trail Media (along with ZDF and Spiegel), was mentioned as one of the best investigations of the year in German by the Global Investigative Journalism Network gijn.org/stories/2024...
Government Coalition Collapse, Green-Washing Natural Gas, Europe’s Opioid Crisis: 2024’s Best Investigative Stories in German
Also featured on our list, a #MeToo case in higher education, secret funding of ‘race science,’ and the state of Swiss prisons.
gijn.org
December 31, 2024 at 10:20 PM
For The Examination, together with Madlen Davies, David Ovalle and the #worldofpain crossborder team of journalists, I investigated Mundipharma, the global counterpart of notorious opioid producer Purdue www.washingtonpost.com/health/2024/... and www.theexamination.org/articles/in-...
In the U.S., opioid-maker Purdue is bankrupt. Its global counterparts make millions.
Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an investigation shows.
www.washingtonpost.com
December 31, 2024 at 10:20 PM
Piotr Ozieranski, Mostafa Elsharkawy and I tracked pharma industry payments to NHS trusts and found the transparency lacking. www.bmj.com/node/1102383...
Pharma pours millions into the NHS for non-research work—but we don’t know what the money is being spent on
Many industry payments to NHS organisations are unexplained and disclosure figures can’t be trusted. This raises questions about unrecognised conflicts of interest, find Hristio Boytchev , Piotr Ozier...
www.bmj.com
December 31, 2024 at 10:20 PM